Skip to main content

Table 4 Participant characteristics

From: How does the clinical practice of Aotearoa New Zealand podiatrists align with international guidelines for the prevention of diabetes-related foot disease? A cross-sectional survey

   

Total

Private

Public

P value

Screening frequency of the very low, moderate, and high-risk foota

Screening of the very low risk (IWGDF 0) foot n (%)

Initial consult only

14 (27)

12 (32)

1 (9)

0.14

Every 1-3 Months

0 (0)

0 (0)

0 (0)

1.00

Every 3-6 Months

4 (8)

2 (5)

2 (18)

0.56

Every 6-12 Months

8 (15)

5 (13)

1 (9)

1.00

Annually

23 (44)

18 (47)

6 (54)

0.94

Never

3 (6)

1 (3)

1 (9)

0.95

 

Screening of the low risk foot (IWGDF 1) n (%)

Initial consult only

2 (4)

2 (5)

0 (0)

0.25

Every 1-3 Months

7 (14)

3 (8)

4 (36)

0.06

Every 3-6 Months

21 (43)

17 (45)

4 (36)

0.85

Every 6-12 Months

9 (18)

7 (18)

2 (18)

0.86

Annually

10 (20)

9 (24)

1 (9)

0.43

Never

0 (0)

0 (0)

0 (0)

1.00

 

Screening of the moderate-high risk foot (IWGDF 2-3) n (%)

Initial consult only

0 (0)

0 (0)

0 (0)

1.00

Every 1-3 Months

24 (49)

16 (42)

8 (73)

0.11

Every 3-6 Months

14 (29)

13 (34)

1 (9)

0.10

Every 6-12 Months

5 (10)

3 (8)

2 (18)

0.39

Annually

6 (12)

6 (16)

0 (0)

0.09

Never

0 (0)

0 (0)

0 (0)

1.00

Diagnostic tests utilised in practice (peripheral vascular supply)b

Manual palpation of pulses

52 (100)

37 (100)

11 (100)

0.96

Capillary refill time/SVPFT

44 (85)

22 (59)

9 (82)

0.98

Temperature gradient

35 (67)

32 (86)

9 (82)

0.56

Doppler examination (with waveform)

27 (52)

16 (43)

10 (91)

0.14

Doppler examination (without waveform)

20 (38)

18 (49)

1 (9)

0.01

Toe systolic pressure (absolute toe pressure)

14 (27)

5 (14)

6 (55)

0.20

Ankle brachial index

12 (23)

3 (8)

5 (45)

0.29

Toe brachial index

9 (17)

7 (19)

5 (45)

0.14

Ankle systolic pressure

5 (10)

1 (3)

3 (27)

0.10

Other

5 (10)

1 (3)

3 (27)

0.10

Diagnostic tests utilised in practice (peripheral neurological supply)b

10g Monofilament

52 (100)

37 (100)

11 (100)

0.78

Sharp/Blunt

31 (60)

21 (57)

7 (64)

0.72

Hot/Cold

26 (50)

18 (49)

7 (64)

0.85

128Hz Tuning fork

25 (48)

17 (46)

5 (45)

0.79

Light Touch

25 (48)

16 (43)

6 (55)

0.86

Joint Position Test

25 (48)

16 (43)

5 (45)

0.84

Reflexes (Achilles/patella)

21 (40)

15 (41)

4 (36)

0.83

Diabetic Neuropathy Symptom Score

14 (27)

8 (22)

4 36)

0.62

Biosthesiometer

11 (21)

6 (16)

3 (27)

0.72

Ipswich Touch Test

10 (19)

4 (11)

6 (55)

0.02

Two Point Discrimination

5 (10)

4 (11)

0 (0)

0.70

Other:

2 (4)

1 (3)

0 (0)

0.26

  1. aLow risk foot (IWGDF 1) in gory in order to align the IWGDF risk stratification system with the NZSSD risk stratification system widely utilised within New Zealand. bParticipants were able to select multiple answers